CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 269 participants.
Also called NCT06886113
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 269 participants
- Sponsor
- Shenzhen Core Medical Technology CO.,LTD.
- Registry
-
NCT06886113
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06886113. Randomized; no masking; primary purpose treatment. Start 2025-10-01 (anticipated); primary completion 2026-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial
- Acronym
- Corvad AMICS
- Condition
- Cardiogenic Shock
- Intervention (Device)
- Conventional circulatory support
- Intervention (Device)
- CorVad
- Lead sponsor
- Shenzhen Core Medical Technology CO.,LTD.
Record details
- Record id
cardio:ct-nct06886113- Content hash
b267001ede6a9c3c64422b20a2629998506f6393fa28b0df5093d28de4d24eff